TCMBANKIN033755 |
Cissampareine |
Antibiotic from Cissampelos pareira; CHEMBL2063771; cissampareine; NSC-79640; Warifteine 7''-methyl ether; CISSAMPAREINE; 32728-54-4; NSC79640 |
C37H38N2O6 |
606.71 |
CN1CCC2=CC(=C(C3=C2C1CC4=CC=C(COC5=C(C=C6CCN=C(C6=C5O)CC7=CC=C(O3)C=C7)OC)C=C4)OC)OC |
TCMBANKIN034042 |
Cycleaneonine |
AC1L4M0U; 2,3,8,13,13a,14,15,16,25,25a-Decahydro-18,19,30-trimethoxy-1,14-dimethyl-4,6:9,12:21,24-trietheno-1H-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolin-5-ol; AC1Q58EH; 4,6:9,12:21,24-Trietheno-1H-pyrido(3',2':14,15)(1,11)dioxacycloeicosino(2,3,4-ij)isoquinolin-5-ol, 2,3,8,13,13a,14,15,16,25,25a-decahydro-18,19,30-trimethoxy-1,14-dimethyl-; 116520-07-1; 9,10,25-trimethoxy-15,30-dimethyl-7,23-dioxa-15,30-diazaheptacyclo[22.6.2.23,6.218,21.18,12.016,35.027,31]heptatriaconta-3,5,8(35),9,11,18,20,24,26,31,33,36-dodecaen-32-ol(non-preferred name); cycleaneonine |
C38H42N2O6 |
622.75 |
CN1CCC2=CC(=C3C(=C2C1CC4=CC=C(C=C4)OC5=C6C(CC7=CC=C(CO3)C=C7)N(CCC6=CC(=C5OC)OC)C)O)OC |
TCMBANKIN058005 |
cissamine |
DTXSID00171789; 18556-27-9; 6H-Dibenzo(a,g)quinolizinium, 5,8,13,13a-tetrahydro-2,9-dihydroxy-3,10-dimethoxy-7-methyl-, (7S-cis)-; AC1MIY8A; (S,S)-N-methylscoulerine; (7S,13aS)-2,9-dihydroxy-3,10-dimethoxy-7-methyl-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinolinium; (7S,13aS)-3,10-dimethoxy-7-methyl-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinolin-7-ium-2,9-diol; Cyclanoline; ZINC255226625; CHEBI:76923; S-trans-cyclanoline; (S)-cis-N-methylscoulerine; (6S,12BS)-4,11-DIHYDROXY-3,10-DIMETHOXY-6-METHYL-7,8,12B,13-TETRAHYDRO-5H-6-AZATETRAPHEN-6-IUM; Cissamine;cyclanoline |
C20H24NO4+ |
342.4 g/mol |
C[N+]12CCC3=CC(=C(C=C3C1CC4=C(C2)C(=C(C=C4)OC)O)O)OC |
TCMBANKIN061873 |
aristolochicacid |
8-Methoxy-3,4-methylendioxxy-10-nitro-1-phenanthrencarbonsaeure; NCGC00095981-03; aristolochic acid; API0000398; TNP00273; MolPort-001-797-985; Bio1_000907; DivK1c_006544; Aristolochind; 8-METHOXY-6-NITROPHENANTHROL(3,4-D)-1,3-DIOXIDE-5-; IDI1_033910; Aristolochin; NCIMech_000812; C-20352; 8-methoxy-6-nitro-2H-phenanthro[3,4-d]1,3-dioxolene-5-carboxylic acid; aris-tolochic acid; Phenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-; NCGC00017334-04; HMS1791H22; CTK4G6973; CC-24181; KBio2_004204; KBio2_006772; SC-14173; NSC 11926; KBioGR_002387; DTXSID0040969; Aristolochic acid I, powder; SR-05000002369-3; CHEBI:2825; 8-Methoxy-6-nitrophenanthro[3,4-d][1,3]dioxole-5-carboxylic acid; Spectrum2_000822; KBioSS_001636; KBio3_002068; CCG-36162; 8-METHOXY-6-NITROPHENANTHROL(3,4-D)-1,3-DIOXIDE-5-CARBOXYLIC ACID; CCRIS 1544; NCGC00095981-04; 61117-05-3; NCGC00095981-02; 313A677; SPBio_000743; 8-Methoxy-6-Nitrophenanthol-(3,4-d)-1,3-Dioxole-5-Carboxylic Acid; I07-0211; ZINC52; Q-100394; C17H11NO7; AB0028965; NCI60_000460; C08469; Aristolochic acid 1; Spectrum5_000729; KBio2_002728; TR 1736; 8-methoxy-6-nitronaphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid; MLS002695974; Aristolochid; ST50307164; SCHEMBL166284; 313-67-7; KBioGR_000160; Phenanthro[3,4-d]-1,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-; Bio2_000640; Ambotz313-67-7; Aristolochic acid I, European Pharmacopoeia (EP) Reference Standard; Tardolyt; AC1L1D86; NSC 50413; KBio2_005296; 8-Methoxy-6-nitro-phenanthro[3,4-d][1,3]dioxole-5-carboxylic acid; 8-methoxy-6-nitro-2H-phenanthro[4,3-d]1,3-dioxolene-5-carboxylic acid; NSC50413; 94218WFP5T; BSPBio_001440; SR-05000002369-2; CHEMBL93353; 3,4-Methylenedioxy-8-methoxy-10-nitro-1-phenanthrenecarboxylic acid; HMS1361H22; N2032; FT-0602867; NCGC00017334-01; LS-21656; Aristolochic acid I; ST057179; Bio1_001396; HMS3402H22; Aristolochiazaeure; KBio3_000319; 8-methoxy-6-nitrophenanthro(3,4-d)-1,3-dioxole-5-carboxylic acid; NCGC00095981-01; AKOS015896751; Aristolochia yellod; HSDB 7179; NCGC00017334-07; NSC11926; Descresepd; BBFQZRXNYIEMAW-UHFFFAOYSA-N; Aristolochic-acid-A; Spectrum_001156; MFCD00004996; AN-319; KBio3_000320; NSC-50413; NCGC00017334-06; ARISTOLOCHINE; UNII-94218WFP5T; MLS002702976; X1086; NSC-11926; Aristolochic acid-I; 8-Methoxy-6-nitrophenanthol (3,4-d) 1,3-dioxole-5-carboxylic acid; EINECS 206-238-3; KBio2_000160; SPECTRUM1502233; NCGC00017334-03; Bio1_000418; TR-013344; 8-methoxy-6-nitro-naphtho[2,1-g][1,3]benzodioxole-5-carboxylic acid; NCGC00095981-05; SR-05000002369; Phenanthro[3,3-dioxole-5-carboxylic acid, 8-methoxy-6-nitro-; BSPBio_002848; HMS1989H22; BDBM50306855; Aristinic acid; Bio2_000160; NCGC00017334-05; 8-Methoxy-3,4-methylenedioxy-10-nitrophenanthrene-1-carboxylic acid; Aristolochia, European Pharmacopoeia (EP) Reference Standard; SpecPlus_000448; Aristolochic acid A; Birthwort; Spectrum3_001114; KBioSS_000160; CCG-35796; Phenanthro[3,4-d]-1,3-dioxole-5-carbocylic acid, 8-methoxy-6-nitro-; MCULE-3861334509; NCGC00017334-02; KBio1_001488; Aristolochic acid; 8-Methoxy-6-nitrophenanthro[3,4-d][1,3]dioxole-5-carboxylic acid #; 12770-90-0; KBio2_001636; Spectrum4_001952; BRN 0345159; A000071790; Tardolyd; SMR001562128;aristolochic acid A;aristolochic acid a |
C17H11NO7 |
341.27 g/mol |
COC1=CC=CC2=C3C(=C(C=C21)[N+](=O)[O-])C(=CC4=C3OCO4)C(=O)O |